Trial Profile
Vagal Stimulation in POTS - The Autonomic Inflammatory Reflex (Pilot 3)
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Mar 2023
Price :
$35
*
At a glance
- Drugs Galantamine (Primary) ; Pyridostigmine (Primary)
- Indications Postural orthostatic tachycardia syndrome
- Focus Therapeutic Use
- 16 Mar 2023 Planned End Date changed from 1 Jun 2023 to 1 Dec 2024.
- 16 Mar 2023 Planned primary completion date changed from 1 Feb 2023 to 1 Jun 2024.
- 27 Oct 2022 Planned End Date changed from 1 Dec 2022 to 1 Jun 2023.